GS
Gregory Sargen
Director

Gregory Sargen insider trades: Avid Bioservices (CDMO) stock sales

Director, Avid Bioservices Last trade Apr 11, 2023 52 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
17
Open-market trades
since 2006
4
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gregory reports to the SEC

Open-market buys and sales

17 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 11, 2023CDMO↓ Sell$142K
Dec 4, 2019CBM↓ Sell$10.0M
Feb 15, 2019CBM↓ Sell$217K
May 8, 2018CBM↓ Sell$3.3M
Feb 7, 2017CBM↓ Sell$1.6M
Nov 11, 2016CBM↓ Sell$1.2M
Mar 9, 2016CBM↓ Sell$1.1M
Feb 11, 2016CBM↓ Sell$493K
Nov 13, 2015CBM↓ Sell$1.4M
Aug 3, 2015CBM↓ Sell$2.0M
May 11, 2015CBM↓ Sell$961K
Feb 12, 2015CBM↓ Sell$816K
Aug 5, 2014CBM↓ Sell$1.1M
Feb 18, 2014CBM↓ Sell$834K
Nov 11, 2013CBM↓ Sell$378K
May 7, 2012CBM↓ Sell$31K
Nov 15, 2006CBM↓ Sell$1.4M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Gregory Sargen's insider trades

Gregory Sargen is a director at Avid Bioservices (CDMO). Since Nov 15, 2006, Gregory has reported no open-market purchases and 17 sales worth $27.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (34 filings), option exercises (22 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CDMO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.